Tokiwa, which holds over 660 worldwide patents for its unique formulations and componentry, currently owns and operates five cosmetic manufacturing sites in Japan, plus others in China and the Philippines. It maintains sales offices in Tokyo, Paris, New York and Shanghai, to serve the needs of cosmetic companies and brands around the world.
The new facility, located in Monroe Township, NJ, encompasses a 153,000-plus sq. ft. standalone building, located on 12-plus acres. The FDA registered facility will be capable of producing OTC and SPF rated products and will operate under cGMP certification.
Included will be a fully operational R&D laboratory, staffed with both Japanese and locally based formulators and chemists. The makeup products that will be produced in the U.S. facility will be many of the same items as currently produced in Japan. Tokiwa is a full-service provider, currently supplying nearly 90% of their products on a turnkey basis, utilizing both their original formulations and componentry.
Robert Congionti, VP of operations, stated: “Our company’s objective is to deliver Japanese quality and standards at competitive prices for all our customers.” A planned completion date has been set for the beginning of the second quarter 2019.
More info: See BeautyPackaging.com